Please login to the form below

Not currently logged in
Email:
Password:

Intellectual property

This page shows the latest Intellectual property news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk signs deal for Prothena's heart drug worth up to $1.2bn

Novo Nordisk signs deal for Prothena's heart drug worth up to $1.2bn

Under the terms of the agreement, Novo Nordisk will gain full worldwide rights to the intellectual property and related rights to Prothena’s ATTR amyloidosis business and pipeline.

Latest news

More from news
Approximately 4 fully matching, plus 292 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 42 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 13 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Purple Agency

An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....

Latest intelligence

Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...